促炎细胞因子的多态性及其对口腔癌前病变和口腔癌的遗传易感性。 - Suppr

Polymorphism in pro-inflammatory cytokines and their genetic susceptibility towards oral precancerous lesions and oral cancer.

作者信息

Yasasve Madhavan, Manjusha Muralidharan, Saravanan Muthupandian

机构信息

AMR and Nanomedicine Laboratory, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai 600077, Tamil Nadu, India.

出版信息

Oral Oncol. 2022 Oct;133:106027. doi: 10.1016/j.oraloncology.2022.106027. Epub 2022 Jul 19.

DOI:10.1016/j.oraloncology.2022.106027

PMID:35868098

Abstract

摘要

相似文献

Polymorphism in pro-inflammatory cytokines and their genetic susceptibility towards oral precancerous lesions and oral cancer.

Oral Oncol. 2022 Oct;133:106027. doi: 10.1016/j.oraloncology.2022.106027. Epub 2022 Jul 19.

Genetic driver events in premalignancy: LOH validated for marking the risk of oral cancer.

Cancer Prev Res (Phila). 2012 Sep;5(9):1073-4. doi: 10.1158/1940-6207.CAPR-12-0220. Epub 2012 Aug 21.

Predicting progression of oral dysplasia--letter.

Cancer Prev Res (Phila). 2013 Jun;6(6):614-5. doi: 10.1158/1940-6207.CAPR-13-0072. Epub 2013 Apr 16.

Interaction of tobacco chewing and smoking habit with interleukin 6 promoter polymorphism in oral precancerous lesions and oral cancer.

Eur Arch Otorhinolaryngol. 2021 Oct;278(10):4011-4019. doi: 10.1007/s00405-021-06620-z. Epub 2021 Jan 27.

Genetic polymorphism of drug metabolizing enzymes (GSTM1 and CYP1A1) as risk factors for oral premalignant lesions and oral cancer.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2012 Sep;156(3):253-9. doi: 10.5507/bp.2012.013. Epub 2012 Jan 30.

Validation of LOH profiles for assessing oral cancer risk.

Cancer Prev Res (Phila). 2012 Sep;5(9):1075-7. doi: 10.1158/1940-6207.CAPR-12-0294. Epub 2012 Aug 21.

Predicting progression of oral dysplasia--response.

Cancer Prev Res (Phila). 2013 Jun;6(6):616. doi: 10.1158/1940-6207.CAPR-13-0111. Epub 2013 Apr 16.

Update on molecular pathology in oral cancer and precancer.

Anticancer Res. 2008 Mar-Apr;28(2B):1197-205.

[Loss of heterozygosity as a tool in the evaluation of cancer risk in premalignant lesions of the head and neck].

Bull Cancer. 2000 Jun;87(6):446.

Potentially malignant lesions and conditions of the mouth and oropharynx: natural history--cellular and molecular markers of risk.

Eur J Cancer Prev. 1993 Jun;2 Suppl 2:31-51. doi: 10.1097/00008469-199306000-00007.

引用本文的文献

Cytokine-based immunotherapy for gastric cancer: targeting inflammation for tumor control.

Explor Target Antitumor Ther. 2025 Apr 26;6:1002312. doi: 10.37349/etat.2025.1002312. eCollection 2025.

Systematic evaluation of TP53 codon 72 polymorphism associated with onset and progression of oral potentially malignant disorders.

BMC Oral Health. 2023 Sep 12;23(1):659. doi: 10.1186/s12903-023-03316-0.

Perspectives on association of genetic polymorphism in Th1/Th2-related cytokines with the risk of oral precancerous lesions.

J Dent Sci. 2023 Jul;18(3):1435-1438. doi: 10.1016/j.jds.2023.03.014. Epub 2023 Mar 31.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Polymorphism in pro-inflammatory cytokines and their genetic susceptibility towards oral precancerous lesions and oral cancer.

作者信息

Yasasve Madhavan, Manjusha Muralidharan, Saravanan Muthupandian

机构信息

AMR and Nanomedicine Laboratory, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai 600077, Tamil Nadu, India.

出版信息

Oral Oncol. 2022 Oct;133:106027. doi: 10.1016/j.oraloncology.2022.106027. Epub 2022 Jul 19.

DOI:10.1016/j.oraloncology.2022.106027

PMID:35868098

Abstract

摘要

相似文献

Polymorphism in pro-inflammatory cytokines and their genetic susceptibility towards oral precancerous lesions and oral cancer.

Oral Oncol. 2022 Oct;133:106027. doi: 10.1016/j.oraloncology.2022.106027. Epub 2022 Jul 19.

Genetic driver events in premalignancy: LOH validated for marking the risk of oral cancer.

Cancer Prev Res (Phila). 2012 Sep;5(9):1073-4. doi: 10.1158/1940-6207.CAPR-12-0220. Epub 2012 Aug 21.

Predicting progression of oral dysplasia--letter.

Cancer Prev Res (Phila). 2013 Jun;6(6):614-5. doi: 10.1158/1940-6207.CAPR-13-0072. Epub 2013 Apr 16.

Interaction of tobacco chewing and smoking habit with interleukin 6 promoter polymorphism in oral precancerous lesions and oral cancer.

Eur Arch Otorhinolaryngol. 2021 Oct;278(10):4011-4019. doi: 10.1007/s00405-021-06620-z. Epub 2021 Jan 27.

Genetic polymorphism of drug metabolizing enzymes (GSTM1 and CYP1A1) as risk factors for oral premalignant lesions and oral cancer.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2012 Sep;156(3):253-9. doi: 10.5507/bp.2012.013. Epub 2012 Jan 30.

Validation of LOH profiles for assessing oral cancer risk.

Cancer Prev Res (Phila). 2012 Sep;5(9):1075-7. doi: 10.1158/1940-6207.CAPR-12-0294. Epub 2012 Aug 21.

Predicting progression of oral dysplasia--response.

Cancer Prev Res (Phila). 2013 Jun;6(6):616. doi: 10.1158/1940-6207.CAPR-13-0111. Epub 2013 Apr 16.

Update on molecular pathology in oral cancer and precancer.

Anticancer Res. 2008 Mar-Apr;28(2B):1197-205.

[Loss of heterozygosity as a tool in the evaluation of cancer risk in premalignant lesions of the head and neck].

Bull Cancer. 2000 Jun;87(6):446.

Potentially malignant lesions and conditions of the mouth and oropharynx: natural history--cellular and molecular markers of risk.

Eur J Cancer Prev. 1993 Jun;2 Suppl 2:31-51. doi: 10.1097/00008469-199306000-00007.

引用本文的文献

Cytokine-based immunotherapy for gastric cancer: targeting inflammation for tumor control.

Explor Target Antitumor Ther. 2025 Apr 26;6:1002312. doi: 10.37349/etat.2025.1002312. eCollection 2025.

Systematic evaluation of TP53 codon 72 polymorphism associated with onset and progression of oral potentially malignant disorders.

BMC Oral Health. 2023 Sep 12;23(1):659. doi: 10.1186/s12903-023-03316-0.

Perspectives on association of genetic polymorphism in Th1/Th2-related cytokines with the risk of oral precancerous lesions.

J Dent Sci. 2023 Jul;18(3):1435-1438. doi: 10.1016/j.jds.2023.03.014. Epub 2023 Mar 31.

Polymorphism in pro-inflammatory cytokines and their genetic susceptibility towards oral precancerous lesions and oral cancer.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Polymorphism in pro-inflammatory cytokines and their genetic susceptibility towards oral precancerous lesions and oral cancer.

作者信息

机构信息

出版信息

相似文献

引用本文的文献